Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

A first of its kind surgery to help people with a specific type of heart failure is going through clinical trials at Providence St. Vincent’s.

Phase 3 trials demonstrated ENCELTO significantly slowed macular photoreceptor loss in MacTel patients over 24 months.

The approval of neffy marks the first major advancement in epinephrine delivery for patients over four years of age in more ...

This is just the new way of consuming nicotine,” a vape shop owner in West Campus says of continuing to sell flavored vapes.

Joseph Shea, who sells athletic wear in Myrtle Beach, South Carolina, wonders and worries about the food he eats.

An Australian man in his forties has become the first person in the world to leave hospital with an artificial heart made of ...

In the SWIFT and ANCHOR trials, depemokimab demonstrated statistically significant reductions in nasal polyp size, ...

MacTel is a rare, progressive eye disease that affects the macula and causes a gradual deterioration in central vision.

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

It’s been just six months since Zevra Therapeutics scored an FD | Niemann-Pick disease type C therapy Miplyffa became ...